Skip to content
Clinical Trials for Alzheimer's Disease

Tennessee

Alzheimer's disease clinical trials in Tennessee

16 Alzheimer's disease studies are recruiting participants at sites in 9 cities across Tennessee as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Tennessee city with a recruiting study

Nashville (10), Cordova (5), Crossville (1), Harriman (1), Knoxville (1), Lenoir City (1), Murfreesboro (1), Oak Ridge (1), Sevierville (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Tennessee

Basic details from each study's public record (the 12 most recently updated of 16). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Nashville
    Registry record
    NCT07177352 · updated
  2. Tennessee Alzheimer's Project

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Vanderbilt University Medical Center
    Recruiting in
    Nashville
    Registry record
    NCT05372172 · updated
  3. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Recruiting in
    Nashville
    Registry record
    NCT06585787 · updated
  4. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Cordova
    Registry record
    NCT06976216 · updated
  5. Alzheimer's Tau Platform: Master Protocol

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Paul S. Aisen
    Recruiting in
    Nashville
    Registry record
    NCT06957418 · updated
  6. A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

    • Phase 4
    • Ages 50 and older
    • All sexes
    Sponsor
    Alpha Cognition, Inc
    Recruiting in
    Cordova
    Registry record
    NCT07633470 · updated
  7. Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    • Phase 2
    • Ages 55 to 80
    • All sexes
    Sponsor
    Lighthouse Pharmaceuticals, Inc.
    Recruiting in
    Nashville
    Registry record
    NCT06847321 · updated
  8. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Celgene
    Recruiting in
    Cordova · Nashville
    Registry record
    NCT06808984 · updated
  9. Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    NewAmsterdam Pharma
    Recruiting in
    Nashville
    Registry record
    NCT07794670 · updated
  10. A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

    • Phase 1/2
    • Ages 50 to 90
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Cordova
    Registry record
    NCT07599670 · updated
  11. A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

    • Phase 1/2
    • Ages 35 to 85
    • All sexes
    Sponsor
    AC Immune SA
    Recruiting in
    Cordova
    Registry record
    NCT05462106 · updated
  12. Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

    • Phase 2
    • Ages 18 to 55
    • All sexes
    Sponsor
    Vanderbilt University Medical Center
    Recruiting in
    Nashville
    Registry record
    NCT05231798 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Tennessee on ClinicalTrials.gov.

Ask about studies in Tennessee

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call